In an assessment of TCGA glioma and the Chinese Glioma Genomic Atlas (CGGA) data, overexpression of SLAMF8 was associated with progression, higher grade glioma, and it was a biomarker for the mesenchymal subtype. The gene discussed is SLAMF8; the disease is central nervous system cancer.